Does liver resection while curative surgery for T2a gallbladder cancer should be performed?

The effect of liver resection while curative surgery for T2a gallbladder cancer : prospective randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009498

Enrollment

134

Registered

2024-06-03

Start date

2024-07-01

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : conventional extended cholecystectomy (including liver resection) vs extended cholecystectomy without liver resection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? patients with pathologically T2a stage and proven to be adenocarcinoma ? patients with age between 30 and 80 old ? patients who can be performed curative resection for gallbladder cancer ? patients who have no recurrence for 5 years after resection for another malignancy

Exclusion criteria

Exclusion criteria: ? patients with pathologically T2b or T3 stage ? patients with peritoneal seeding or distant metastasis ? patients with other malignancy of certain organ or patients within 5 years after surgery for other malignacy ? patients who cannot be underwent R0 resection ? patients with direct invasion of liver by GB cancer on preoperative or intraoperative findings ? pathologically another malgnancy of gallbladder (such as adenosquamous, neuroendocrine turmor, etc) except adenocarcinoma ? patients who was underwent R1 or R2 resection after pathologic report.

Design outcomes

Primary

Measure	Time frame
3-year overall survival	—

Secondary

Measure	Time frame
3-year disease free survival	—

Countries

Korea, Republic of

Contacts

Public ContactDong Do You

The Catholic University of Korea, St. Vincent's Hospital

tzanggu@catholic.ac.kr+82-31-881-8954

Outcome results